In this context, mHLA-DR might be a useful tool for their differential diagnosis, reflecting the known physiopathology of HLH driven by IFN-γ production, leading to an enhanced and dysregulated activation of CD8+ cytotoxic T cells and monocytes. The gene discussed is CD8A; the disease is hemophagocytic syndrome.